fidexaban has been researched along with Coronary Artery Disease in 2 studies
Fidexaban: structure in first source
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Arterial thrombus formation was measured in Badimon Chamber at baseline, end-of-infusion [EoI], and four hours and eight hours after EoI, and factor-X activity, prothrombin time [PT] ratio and plasma drug levels were measured simultaneously." | 2.73 | Potent arterial antithrombotic effect of direct factor-Xa inhibition with ZK-807834 administered to coronary artery disease patients. ( Chesebro, JH; Crook, J; Farkouh, ME; Fuster, V; Leadley, R; Osende, J; Palencia, S; Shimbo, D; Zafar, MU, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doggrell, SA | 1 |
| Zafar, MU | 1 |
| Farkouh, ME | 1 |
| Osende, J | 1 |
| Shimbo, D | 1 |
| Palencia, S | 1 |
| Crook, J | 1 |
| Leadley, R | 1 |
| Fuster, V | 1 |
| Chesebro, JH | 1 |
1 review available for fidexaban and Coronary Artery Disease
| Article | Year |
|---|---|
Is there evidence to support the use of direct Factor Xa inhibitors in coronary artery disease?
Topics: Amidines; Coronary Artery Disease; Cyclic N-Oxides; Factor Xa; Factor Xa Inhibitors; Humans; Morphol | 2011 |
1 trial available for fidexaban and Coronary Artery Disease
| Article | Year |
|---|---|
Potent arterial antithrombotic effect of direct factor-Xa inhibition with ZK-807834 administered to coronary artery disease patients.
Topics: Amidines; Animals; Aorta; Blood Coagulation; Coronary Artery Disease; Dose-Response Relationship, Dr | 2007 |